testosterone undecanoate: Clinical Trials

17 trials of testosterone undecanoate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 2 unknown. 17 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 317Completed 15, Unknown 2
Phase 23Completed 3

Follow testosterone undecanoate: new trials by email Literature Review of testosterone undecanoate trials Research Report on testosterone undecanoate

Trials (filtered) newest first · largest first

All 17 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Does Human Skeletal Muscle Possess an Epigenetic Memory of Testosterone?
Saline, Testosterone Undecanoate, Saline + Resistance exercise training - Healthy Aging, Age-Related Sarcopenia
Phase 2 / Phase 3CompletedNorwegian School of Sport Sciences452024-09-012026-03-06
The Effects of Semaglutide vs Testosterone Replacement Therapy on Functional Hypogonadism and Sperm Quality in Men With Type 2 Diabetes Mellitus and Obesity
Semaglutide, Testosterone Undecanoate - Type 2 Diabetes Mellitus, Obesity
Phase 3CompletedUniversity Medical Centre Ljubljana252020-09-202024-07-08
A Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Oral Testosterone Undecanoate, Axiron Testosterone Topical Solution - Hypogonadism
Phase 3CompletedClarus Therapeutics, Inc.2222016-03-012018-02-23
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Oral testosterone undecanoate, LPCN 1021, Topical testosterone gel 1.62 % - Male Hypogonadism
Phase 3CompletedLipocine Inc.3152014-02-012017-10-23
Testosterone, Metformin, or Both, for Hypogonadism in Obese Males
Placebo, Metformin, Testosterone Undecanoate - Hypogonadism, Obesity
Phase 3CompletedFundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud1072013-07-042024-12-13
Safety and Efficacy Trial of Testosterone Undecanoate
Oral testosterone undecanoate - Male Hypogonadism
Phase 3CompletedClarus Therapeutics, Inc.1442013-01-012017-12-12
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Oral testosterone undecanoate, Transdermal testosterone gel (AndroGel) - Male Hypogonadism
Phase 3CompletedClarus Therapeutics, Inc.1822012-08-012021-06-28
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Oral testosterone undecanoate, topical testosterone gel - Male Hypogonadism
Phase 3CompletedClarus Therapeutics, Inc.3252011-07-012018-08-14
Androgen for Leydig Cell Proliferation
Testosterone undecanoate, Castor Oil - Klinefelter Syndrome, Hypergonadotropic Hypogonadism
Phase 2 / Phase 3CompletedUniversity of Roma La Sapienza562009-06-012018-09-25
Reandron in Diabetic Men Witn Low Testosterone Level
Reandron 1000, placebo - Type 2 Diabetes, Hypogonadism
Phase 2 / Phase 3CompletedAustin Health882009-01-012014-07-01
Effects of Testosterone Plus Dutasteride or Placebo on Muscle Strength, Body Composition and Metabolism in Transmen
dutasteride 5 mg/day, Testosterone Undecanoate - Transgenderism, Hypogonadism
Phase 3CompletedUnita Complessa di Ostetricia e Ginecologia162008-11-042020-09-11
Long-term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal Men
Testosterone Undecanoate 750 mg, Testosterone Undecanoate 1000 mg - Hypogonadism, Primary Hypogonadism
Phase 3CompletedEndo USA Inc., a Keenova Therapeutics Company5312006-03-012017-10-05
The Effect of IM Testosterone Undecanoate on Biochemical and Anthropometric Characteristics of Metabolic Syndrome in Hypogonadal Men
Nebido (testosterone undecanoate), Placebo - Metabolic Syndrome, Hypogonadism
Phase 3UnknownRussian Academy of Medical Sciences2502005-10-012008-06-13
Testosterone and Its Metabolites in GID
testosterone undecanoate alone, testosterone undecanoate plus letrozole, testosterone undecanoate plus dutasteride - Transsexualism
Phase 3CompletedUnita Complessa di Ostetricia e Ginecologia152005-05-012018-03-21
The Effects of Testosterone and Nutritional Supplementation in the Undernourished Elderly
testosterone undecanoate - Malnutrition, Aging
Phase 3UnknownUniversity of Adelaide2002003-07-012006-09-11
IRAD2 : Patients With Respiratory Failure at Home
education, Oral dietary supplements (563 kcal/d), RESPIFOR, exercises on an ergometric bicycle 3 to 5 times a week - Chronic Respiratory Failure, Nutritional Depletion
Phase 3CompletedUniversity Hospital, Grenoble2002003-04-012009-07-08
Assessment of Long Term Treatment With Testosterone Undecanoate in Males With Hypogonadism
Testosterone undecanoate (TU) - NebidoTM - Hypogonadism
Phase 3CompletedBayer962003-02-012014-12-30

Conditions studied

Hypogonadism (9)  ·  Eunuchism (4)  ·  Diabetes Mellitus, Type 2 (2)  ·  Obesity (2)  ·  Transsexualism (2)  ·  Endocrine System Diseases (1)  ·  Erectile Dysfunction (1)  ·  Gonadal Disorders (1)  ·  Infertility (1)  ·  Insulin Resistance (1)  ·  Klinefelter Syndrome (1)  ·  Malnutrition (1)  ·  Metabolic Syndrome (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  Testicular Neoplasms (1)

Sponsors

Clarus Therapeutics, Inc. (4)  ·  Unita Complessa di Ostetricia e Ginecologia (2)  ·  Austin Health (1)  ·  Bayer (1)  ·  Endo USA Inc., a Keenova Therapeutics Company (1)  ·  Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (1)  ·  Lipocine Inc. (1)  ·  Norwegian School of Sport Sciences (1)  ·  Russian Academy of Medical Sciences (1)  ·  University Hospital, Grenoble (1)  ·  University Medical Centre Ljubljana (1)  ·  University of Adelaide (1)  ·  University of Roma La Sapienza (1)

Countries

United States (5)  ·  Germany (3)  ·  Australia (2)  ·  Italy (2)  ·  France (1)  ·  Norway (1)  ·  Russia (1)  ·  Slovenia (1)  ·  Spain (1)  ·  Switzerland (1)

Top investigators

Ronald Swerdloff, MD (4)  ·  Andrea Isidori, MD, PhD (1)  ·  Andrea Lenzi, MD (1)  ·  Anthony DelConte, MD (1)  ·  Cristina M Meriggiola, MD (1)  ·  Ian M Chapman, MBBS, PhD (1)  ·  Jose Carlos Fernandez-Garcia, MD (1)  ·  Mathis Grossmann (1)  ·  Svetlana Kalinchenko, PhD (1)  ·  Vincenzo Bonifacio, MD, PhD (1)

Results publications

PMID 36272969, PMID 19144729, PMID 20524974, PMID 20718771, PMID 21700760, PMID 24978674, PMID 31532522, PMID 38224135, PMID 38433502, PMID 39252657, PMID 39511836